+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Molecular Imaging Market Size, Share & Trends Analysis Report By Modality (SPECT, NMR), By Application (Oncology, Cardiology), By End-use (Hospitals, Diagnostic Imaging Centers), By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 220 Pages
  • July 2024
  • Region: Global
  • Grand View Research
  • ID: 5990709
Description Jump to:
The global molecular imaging market size is anticipated to reach USD 11.44 billion by 2030, growing at a CAGR of 4.52% from 2024 to 2030, according to a new report. The major factors contributing to market growth include technological advancements, increase in prevalence of cancer, and rising investment in R&D. For instance, according to the International Agency for Research on Cancer, approximately 19,976,499 new cancer cases and 9,743,832 cancer-related deaths were reported globally in 2022.

The growing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions necessitates effective diagnostic tools, which are expected to significantly contribute to the growth of the molecular imaging market. Molecular imaging devices such as PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), and Nuclear Magnetic Resonance (NMR) Spectrometer are particularly efficient in this regard. These advanced technologies provide detailed insights into the metabolic processes, molecular activities, and structural changes associated with various diseases. They enable healthcare professionals to visualize and assess the extent and characteristics of tumors, cardiac function, and neurological abnormalities with high precision and accuracy.

Moreover, molecular imaging facilitates early detection of diseases, even at subclinical stages, allowing for timely intervention and personalized treatment planning. This proactive approach not only improves patient outcomes but also reduces healthcare costs associated with advanced disease stages and complications.

Strategic initiatives undertaken by major market players, including mergers and acquisitions, product launches, regulatory approvals, partnerships, collaborations, and research and development (R&D) activities, play a crucial role in driving the growth of the molecular imaging market. For instance, in January 2024, Bruker Corporation successfully installed a state-of-the-art 1.2 Gigahertz (GHz) NMR system at The Ohio State University's National Gateway Ultrahigh Field NMR Center. This GHz-class NMR system represents a significant advancement in nuclear magnetic resonance (NMR) spectroscopy, aiming to revolutionize research in life sciences and materials science.

Molecular Imaging Market Report Highlights

  • Based on the modality segment, the Single Photon Emission Computed Tomography (SPECT) segment dominated by capturing a share of 43.8% in 2023
  • The Nuclear Magnetic Resonance (NMR) Spectrometer segment is anticipated to grow at the fastest CAGR from 2024 to 2030
  • Based on application, the oncology segment held the largest market share in the application segment by capturing a share of 33.7% in 2023.
  • Based on end use, the hospital segment held a majority share of the market in 2023.
  • Diagnostic imaging centers segment is expected to grow at the fastest rate from 2024 to 2030
  • North America dominated the market with a share of 41.7% in 2023.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Modality
1.2.2. Application
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Molecular Imaging Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of cancer and other chronic diseases
3.2.1.2. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. High Cost of Equipment and Treatment
3.3. Molecular Imaging Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Molecular Imaging Market: Modality Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Molecular Imaging Modality Market Movement Analysis
4.3. Global Molecular Imaging Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
4.4. Molecular Ultrasound Imaging
4.4.1. Molecular ultrasound imaging market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Positron Emission Tomography (PET)
4.5.1. Positron emission tomography (PET) market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Single Photon Emission Computed Tomography (SPECT)
4.6.1. Single photon emission computed tomography (SPECT) market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Nuclear Magnetic Resonance (NMR) Spectrometer
4.7.1. Nuclear Magnetic resonance (NMR) spectrometer market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Other Modalities
4.8.1. Other modalities market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Molecular Imaging Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Molecular Imaging Application Market Movement Analysis
5.3. Global Molecular Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Cardiovascular
5.4.1. Cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Neurology
5.5.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Oncology
5.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Respiratory
5.7.1. Respiratory market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Gastrointestinal
5.8.1. Gastrointestinal market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Molecular Imaging Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Molecular Imaging End Use Market Movement Analysis
6.3. Global Molecular Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Diagnostic Imaging Centers
6.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Research institutes
6.6.1. Research institutes market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Molecular Imaging Market: Regional Estimates & Trend Analysis By Application, End Use
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Competitive scenario
7.5.1.3. Regulatory framework
7.5.1.4. Reimbursement structure
7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Reimbursement structure
7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework
7.5.3.4. Reimbursement structure
7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Competitive scenario
7.6.1.3. Regulatory framework
7.6.1.4. Reimbursement structure
7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement structure
7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement structure
7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Regulatory framework
7.6.4.4. Reimbursement structure
7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Regulatory framework
7.6.5.4. Reimbursement structure
7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Regulatory framework
7.6.6.4. Reimbursement structure
7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Regulatory framework
7.6.7.4. Reimbursement structure
7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Competitive scenario
7.6.8.3. Regulatory framework
7.6.8.4. Reimbursement structure
7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Competitive scenario
7.7.1.3. Regulatory framework
7.7.1.4. Reimbursement structure
7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement structure
7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement structure
7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Competitive scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement structure
7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Competitive scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement structure
7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Competitive scenario
7.7.6.3. Regulatory framework
7.7.6.4. Reimbursement structure
7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Competitive scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement structure
7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Argentina
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement structure
7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Competitive scenario
7.9.1.3. Regulatory framework
7.9.1.4. Reimbursement structure
7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Competitive scenario
7.9.2.3. Regulatory framework
7.9.2.4. Reimbursement structure
7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Competitive scenario
7.9.3.3. Regulatory framework
7.9.3.4. Reimbursement structure
7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Competitive scenario
7.9.4.3. Regulatory framework
7.9.4.4. Reimbursement structure
7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Key company market share analysis, 2023
8.4. Company Position Analysis
8.5. Company Categorization (Emerging Players, Innovators and Leaders
8.6. Company Profiles
8.6.1. Bruker
8.6.1.1. Company overview
8.6.1.2. Financial performance
8.6.1.3. Product benchmarking
8.6.1.4. Strategic initiatives
8.6.2. GE HealthCare
8.6.2.1. Company overview
8.6.2.2. Financial performance
8.6.2.3. Product benchmarking
8.6.2.4. Strategic initiatives
8.6.3. Siemens Healthineers
8.6.3.1. Company overview
8.6.3.2. Financial performance
8.6.3.3. Product benchmarking
8.6.3.4. Strategic initiatives
8.6.4. Koninklijke Philips N.V.
8.6.4.1. Company overview
8.6.4.2. Financial performance
8.6.4.3. Product benchmarking
8.6.4.4. Strategic initiatives
8.6.5. Canon Medical Systems Corporation
8.6.5.1. Company overview
8.6.5.2. Financial performance
8.6.5.3. Product benchmarking
8.6.5.4. Strategic initiatives
8.6.6. Mediso, Cubresa Inc.
8.6.6.1. Company overview
8.6.6.2. Financial performance
8.6.6.3. Product benchmarking
8.6.6.4. Strategic initiatives
8.6.7. Shimadzu Corporation
8.6.7.1. Company overview
8.6.7.2. Financial performance
8.6.7.3. Product benchmarking
8.6.7.4. Strategic initiatives
8.6.8. United Imaging Healthcare Co
8.6.8.1. Company overview
8.6.8.2. Financial performance
8.6.8.3. Product benchmarking
8.6.8.4. Strategic initiatives
8.6.9. Positron Corporation
8.6.9.1. Company overview
8.6.9.2. Financial performance
8.6.9.3. Product benchmarking
8.6.9.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America molecular imaging market, By country, 2018 - 2030 (USD Million)
Table 4 North America molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 5 North America molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 6 North America molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 7 U.S. molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 8 U.S. molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 9 U.S. molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 10 Canada molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 11 Canada molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 12 Canada molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 13 Mexico molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 14 Mexico molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 15 Mexico molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 16 Europe molecular imaging market, By country, 2018 - 2030 (USD Million)
Table 17 Europe molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 18 Europe molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 19 Europe molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 20 UK molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 21 UK molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 22 UK molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 23 Germany molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 24 Germany molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 25 Germany molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 26 France molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 27 France molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 28 France molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 29 Italy molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 30 Italy molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 31 Italy molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 32 Denmark molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 33 Denmark molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 34 Denmark molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 35 Sweden molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 36 Sweden molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 37 Sweden molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 38 Norway molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 39 Norway molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 40 Norway molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 41 Asia Pacific molecular imaging market, By country, 2018 - 2030 (USD Million)
Table 42 Asia Pacific molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 43 Asia Pacific molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 44 Asia Pacific molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 45 Japan molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 46 Japan molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 47 Japan molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 48 China molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 49 China molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 50 China molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 51 India molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 52 India molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 53 India molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 54 Australia molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 55 Australia molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 56 Australia molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 57 South Korea molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 58 South Korea molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 59 South Korea molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 60 Thailand molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 61 Thailand molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 62 Thailand molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 63 Latin America molecular imaging market, By Country, 2018 - 2030 (USD Million)
Table 64 Latin America molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 65 Latin America molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 66 Latin America molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 67 Brazil molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 68 Brazil molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 69 Brazil molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 70 Argentina molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 71 Argentina molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 72 Argentina molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 73 Middle East & Africa molecular imaging market, By country, 2018 - 2030 (USD Million)
Table 74 Middle East & Africa molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 75 Middle East & Africa molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 76 Middle East & Africa molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 77 South Africa molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 78 South Africa molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 79 South Africa molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 80 Saudi Arabia molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 81 Saudi Arabia molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 83 UAE molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 84 UAE molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 85 UAE molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 86 Kuwait molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 87 Kuwait molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 88 Kuwait molecular imaging market, By end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Molecular Imaging market: market outlook
Fig. 14 Parent market outlook
Fig. 15 Related/ancillary market outlook
Fig. 16 Penetration and growth prospect mapping
Fig. 17 Industry value chain analysis
Fig. 18 Molecular imaging market driver impact
Fig. 19 Molecular imaging market restraint impact
Fig. 20 Molecular imaging market: Modality movement analysis
Fig. 21 Molecular imaging market: Modality outlook and key takeaways
Fig. 22 Molecular ultrasound imaging market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Positron emission tomography (PET) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Single photon emission computed tomography (SPECT) market estimates and forecast, 2018-2030 (USD Million)
Fig. 25 Nuclear magnetic resonance (NMR) spectrometer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Other modalities market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Molecular imaging market: Application movement analysis
Fig. 28 Molecular imaging market: Application outlook and key takeaways
Fig. 29 Cardiovascular market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Respiratory market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Gastrointestinal market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Molecular imaging market: End use movement analysis
Fig. 35 Molecular imaging market: End use outlook and key takeaways
Fig. 36 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Diagnostic imaging centers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Research institutes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Global molecular imaging market: Regional movement analysis
Fig. 40 Global molecular imaging market: Regional outlook and key takeaways
Fig. 41 North America
Fig. 42 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 U.S.
Fig. 44 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Canada
Fig. 46 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Mexico
Fig. 48 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Europe
Fig. 50 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 UK
Fig. 52 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Germany
Fig. 54 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 France
Fig. 56 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Italy
Fig. 58 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Spain
Fig. 60 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Denmark
Fig. 62 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Sweden
Fig. 64 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Norway
Fig. 66 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Asia Pacific
Fig. 68 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 China
Fig. 70 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Japan
Fig. 72 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 India
Fig. 77 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Thailand
Fig. 76 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 South Korea
Fig. 78 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Australia
Fig. 80 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Latin America
Fig. 82 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Brazil
Fig. 84 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Mexico
Fig. 86 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Argentina
Fig. 88 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Middle East and Africa
Fig. 90 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 South Africa
Fig. 92 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Saudi Arabia
Fig. 94 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 UAE
Fig. 96 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Kuwait
Fig. 98 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 99 Market share of key market players- Molecular imaging market

Companies Mentioned

  • Bruker
  • GE HealthCare
  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Mediso, Cubresa Inc.
  • Shimadzu Corporation
  • United Imaging Healthcare Co
  • Positron Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages220
PublishedJuly 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 8.45 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.44 Billion
Compound Annual Growth Rate4.5%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Global Nuclear Imaging Equipment Market Size, Share & Trends Analysis Report by Modality (SPECT, PET), Application (Cardiology, Oncology, Neurology), End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Nuclear Imaging Equipment Market Size, Share & Trends Analysis Report by Modality (SPECT, PET), Application (Cardiology, Oncology, Neurology), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From
Hybrid Imaging Market Size, Share & Trends Analysis Report By Type (PET/CT, SPET/CT), By Application (Oncology, Cardiology), By End Use (Hospitals, Diagnostic Imaging Centers), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Hybrid Imaging Market Size, Share & Trends Analysis Report By Type (PET/CT, SPET/CT), By Application (Oncology, Cardiology), By End Use (Hospitals, Diagnostic Imaging Centers), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 210 Pages
  • Global
From
Global Imaging Services Market by Modality (CT Scans, MRI Scans, Nuclear Medicine Scans), End-user (Diagnostic Imaging Centers, Hospitals) - Forecast 2024-2030 - Product Image

Global Imaging Services Market by Modality (CT Scans, MRI Scans, Nuclear Medicine Scans), End-user (Diagnostic Imaging Centers, Hospitals) - Forecast 2024-2030

  • Report
  • 188 Pages
  • Global
From
Global Artificial Intelligence in Medical Imaging Market by Offering (Services, Software Tools/Platform), Image Acquisition Technology (Computed Tomography, Magnetic Resonance Imaging, Molecular Imaging), Application, End-user - Forecast 2024-2030 - Product Image

Global Artificial Intelligence in Medical Imaging Market by Offering (Services, Software Tools/Platform), Image Acquisition Technology (Computed Tomography, Magnetic Resonance Imaging, Molecular Imaging), Application, End-user - Forecast 2024-2030

  • Report
  • 198 Pages
  • Global
From
Molecular Imaging Market Size and Forecasts 2024-2034: Global and Regional Share, Trends, and Growth Opportunity Analysis by Technology; Application; and End-User - Product Image

Molecular Imaging Market Size and Forecasts 2024-2034: Global and Regional Share, Trends, and Growth Opportunity Analysis by Technology; Application; and End-User

  • Report
  • 132 Pages
  • Global
From

About the Molecular Imaging Market

Molecular Imaging is a form of medical imaging that uses specialized imaging techniques to detect and measure the activity of molecules in the body. It is used to diagnose and monitor diseases, such as cancer, cardiovascular disease, and neurological disorders. Molecular Imaging can provide detailed information about the structure and function of cells and tissues, which can help physicians make more informed decisions about treatment. It can also be used to monitor the effectiveness of treatments. Molecular Imaging is used in combination with other imaging modalities, such as X-ray, computed tomography (CT), and magnetic resonance imaging (MRI). It is also used in combination with other diagnostic tests, such as blood tests and biopsies. Some of the companies in the Molecular Imaging market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Hitachi Medical Systems, Toshiba Medical Systems, Shimadzu Corporation, and Hologic. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.